Nonthiol ACE inhibitors, enalapril and lisinopril are unable to protect mitochondrial toxicity due to paraquat

Pesticide Biochemistry and Physiology

Volumn 89, Issue 2, 2007, Pages 163-167

  Mohammadi Bardbori, Afshin ^a,b   Ghazi Khansari, Mahmoud ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Enalapril; Isolated rat liver mitochondria; Lisinopril; Nonthiol ACEi; Paraquat

Indexed keywords

RATTUS;

EID: 34548159405     PISSN: 00483575     EISSN: 10959939     Source Type: Journal    
DOI: 10.1016/j.pestbp.2007.06.001     Document Type: Article

References (40)

1. HOPE Investigators, Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MicroHOPE substudy, Lancet 355 (2000) 253-259.
2. H.H Parving, H. Lehnert, J. Brochner-Mortensen, R. Gomis, S. Andersen, P. Arner, Irbersartan in patients with Type 2 Diabetes and Microalbuminuria Study Group, The effect or irbersartan on the development of diabetic nephropathy in patients with type 2 diabetes, N. Engl. J. Med. 345 (2001) 870-878.
3. Park J.B., Intengan H.D., and Schiffrin E.L. Reduction of resistance artery stiffness by treatment with the AT1-receptor antagonist losartan in essential hypertension. J. Renin Angiotensin Aldosterons Syst. 1 (2000) 40-45
4. Munzel T., and Keaney J.R.J.F. Are ACE inhibitors a "magic bullet" against oxidative stress?. Circulation 104 (2001) 1571-1574
5. De Cavanagh E., Inserra F., Ferder L., and Fraga C. Enalapril and captopril enhance glutathione-dependent antioxidant defenses in mouse tissues. Am. J. Physiol. 278 (2000) R572-R577
6. Rueckschloss U., Quinn M.T., Holtz J., and Morawietz H. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells :protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Areterioscler. Thromb. Vasc. Biol. 22 (2002) 1845-1851
7. Koh K.K., Ahn J.Y., Han S.H., Kim D.S., Jin D.K., Kim H.S., Shin M.S., Ahn T.H., Choi I.S., and Shin E.K. Pleiotropic effects of angiotensin II receptor blocker in hypertensive patients. J. Am. Coll. Cardiol. 42 (2003) 905-910
8. Kukreja R.C., Kontos H.A., and Hess M.L. Captopril and enalaprilat do not scavenge the superoxide anion. Am. J. Cardiol. 65 (1990) 24I-27I
9. Mira M.L., Silva M.M., Queiroz M.J., and Manso C.F. Angiotensin converting enzyme inhibitors as oxygen free radical scavengers. Free Radic. Res. Commun. 19 (1993) 173-181
10. Chopra M., Beswick H., Clapperton M., Dargie H.J., Smith W.E., and McMurray J. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl containing ACE inhibitors. Cardiovasc. Pharmacol. 19 (1992) 330-340
11. Ghazi-Khansari M., Nasiri G., and Honarjoo M. Decreasing the oxidant stress from paraquat in isolated perfused rat lung using captopril and niacin. Arch. Toxicol. 79 (2005) 341-345
12. Lambert C.E., and Bondy S.C. Effects of MPTP, MPP{thorn} and paraquat on mitochondrial potential and oxidative stress. Life Sci. 44 (1989) 1277-1284
13. Farrington J.A., Ebert M., Land E.J., and Fletcher K. Bipyridylium salts and related compounds. V. Pulse radiolysis studies of the reaction of paraquat. Biochim. Biophys. Acta 314 (1973) 372-381
14. Ghazi-Khansari M., Mohammadi-bardbori A., and Hosseini M.-J. Using Janus green B to study paraquat toxicity in rat liver mitochondria: role of ACE inhibitors (Thiol and nonthiol ACEi). Ann. N.Y. Acad. Sci. 1090 (2006) 98-107
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J. Immunol. Methods 65 (1983) 55-63
16. Mohammadi-Bardbori A., and Ghazi-Khansari M. Comparative measurement of cyanide and paraquat mitochondrial toxicity using two different mitochondrial toxicity assays. Toxicol. Mech. Methods 17 (2007) 1-5
17. Babincova M., Altanerova V., Altaner E., Baeova Z., and Babinec P. Doxorubicin mediated free iron release from ferritin magnetopartions for cancer therapy at higher temperatures: implications for cancer therapy. Eur. Cells Mater. 2 (2002) 140-141
18. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal. Biochem. 27 (1969) 502-522
19. Zachrias E.S., Shelley R.H., and Pang N.S. Protective effect of liposome-associated α-tocopherol against paraquat-induced acute lung toxicity. Biochem. Pharmacol. 44 (1992) 1811-1818
20. Johansson L.H., and Borg L.A.H. Asectrophotometric method for determination of catalase activity in small tissue samples. Anal. Biochem. 174 (1988) 331-336
21. Wheeler C.R., Salzman J.A., and Elsayed N.M. Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity. Anal. Biochem. 184 (1990) 193-199
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1979) 248-259
23. Ghazi-Khansari M., and Mohammadi-bardbori A. Captopril ameliorated mitochondrial toxicity due to paraquat. Toxicol. In vitro 21 (2006) 403-407
24. Al-Shabanad O., Mansour M., El-Khasef H., and Al-Bekairi A. Captopril ameliorates myocardial and haematological toxicities induced by adriamycin. Biochem. Mol. Biol. Int. 45 (1998) 419-427
25. Aruoma O., Akanumu D., Cecchini R., and Hariwell B. Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species. Chem. Biol. Interact. 77 (1991) 303-314
26. Bartosz M., Kedziora J., and Bartosz G. Antioxidant and pro-oxidant properties of captopril and enalapril. Free. Radic. Biol. Med. 23 (1997) 29-35
27. Benzie I., and Tomlison B. Antioxidant power of angiotensin-converting enzyme inhibitors in vitro. Br. J. Clin. Pharmacol. 45 (1998) 168-169
28. Fernandez-Checa J.C., Kaplovitz N., Garcia-Ruitz C., and Colell A. Mitochondrial glutathione: importance and transport. Semin. Liver Dis. 18 (1998) 389-401
29. DeLeve L.D.N. Kaplowitz, Glutathione metabolism and its role in hepatotoxicity. Pharmacol. Ther. 52 (1991) 287-305
30. Jaeschke H. Glutathione disulfide as index of oxidant stress in rat liver during hypoxia. Am. J. Physiol. 258 (1990) 499-505
31. Aydin S., Aral I., Kilic N., Bakan I., Aydin S., and Erman F. The level of antioxidant enzyme, plasma vitamin C and E in cement plant workers. Clin. Chim. Acta 341 (2004) 193-198
32. Chance B., Sies H., and Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59 (1979) 527-605
33. Hassan H.M., and Fridovich I. Intracellular production of superoxide radical and of hydrogen peroxide by redox active compounds. Arch. Biochem. Biophys. 196 (1979) 385-395
34. Tsukada S., Parsons C.J., and Rippe R.A. Mechanisms of liver fibrosis. Clin. Chim. Acta 364 (2006) 33-60
35. Molteni A., Moulder J.E., Cohen E.P., Fish B.L., Taylor J.M., Veno P.A., Wolfe L.F., and Ward W.F. Prevention of radiation-induced nephropathy and fibrosis in a model of bone marrow transplant by an angiotensin II receptor blocker. Exp. Biol. Med. 226 (2001) 1016-1023
36. Demedts M., Behr J., Buhl R., Costabel U., Dekhuijzen R., Jansen H.M., MacNee W., Thomeer M., Wallaert B., Laurent F., Nicholson A.G., Verbeken E.K., Verschakelen J., Flower C.D., Capron F., Petruzzelli S., De Vuyst P., Van Den Bosch J.M., Rodriguez-Becerra E., Corvasce G., Lankhorst I., Sardina M., Montanari M., and IFIGENIA Study Group. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med. 353 (2005) 2229-2242
37. Costa L.E., La-Padula P., Lores-Arnaiz S., D'Amico G., Boveris A., Kurnjek M.L., and Basso N. Long-term angiotensin II inhibition increases mitochondrial nitric oxide synthase and not antioxidant enzyme activities in rat heart. J. Hypertens. 20 (2002) 2487-2494
38. Williams B. The rennin angiotensin system and cardiovascular disease: hope or hype?. J. Renin Angiotensin Aldosterone Syst. 1 (2000) 142-146
39. Cominacini L., Fratta P.A., and Garbin U. Zafenopril inhibits the expression of adhesion molecules on endothelial cells by reducing reactive oxygen species. Am. J. Hypertens. 15 (2002) 891-895
40. De Cavanagh E.M., Fraga C.G., Ferder L., and Inserra F. Enalapril and captopril enhance antioxidant defenses in mouse tissues. Am. J. Physiol. 272 (1997) 514-518